For those desiring to outshine the market, the strategic selection of individual stocks is paramount. Well-chosen stocks have the potential to substantially boost your wealth.
In the latest session, Kymera Therapeutics Inc (NASDAQ: KYMR) closed at $43.64 down -1.09% from its previous closing price of $44.12. In other words, the price has decreased by -$1.09 from its previous closing price. On the day, 1.14 million shares were traded. KYMR stock price reached its highest trading level at $45.025 during the session, while it also had its lowest trading level at $43.58.
Ratios:
For a deeper understanding of Kymera Therapeutics Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 8.49 and its Current Ratio is at 8.49. In the meantime, Its Debt-to-Equity ratio is 0.11 whereas as Long-Term Debt/Eq ratio is at 0.09.
On June 03, 2025, B. Riley Securities Upgraded its rating to Buy which previously was Neutral but kept the price unchanged to $60.
BofA Securities Upgraded its Neutral to Buy on June 02, 2025, while the target price for the stock was maintained at $51.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Jun 30 ’25 when BAKER BROS. ADVISORS LP bought 655,500 shares for $44.00 per share. The transaction valued at 28,842,000 led to the insider holds 6,117,295 shares of the business.
Ridloff Elena sold 4,500 shares of KYMR for $225,000 on Jun 11 ’25. The Director now owns 0 shares after completing the transaction at $50.00 per share. On Jun 11 ’25, another insider, ELENA RIDLOFF, who serves as the Director of the company, bought 4,500 shares for $48.60 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, KYMR now has a Market Capitalization of 3061961216 and an Enterprise Value of 2464997888. For the stock, the TTM Price-to-Sale (P/S) ratio is 48.26 while its Price-to-Book (P/B) ratio in mrq is 3.61. Its current Enterprise Value per Revenue stands at 41.861 whereas that against EBITDA is -9.074.
Stock Price History:
The Beta on a monthly basis for KYMR is 2.18, which has changed by 0.44407678 over the last 52 weeks, in comparison to a change of 0.12632763 over the same period for the S&P500. Over the past 52 weeks, KYMR has reached a high of $53.27, while it has fallen to a 52-week low of $19.44. The 50-Day Moving Average of the stock is 18.07%, while the 200-Day Moving Average is calculated to be 10.63%.
Shares Statistics:
For the past three months, KYMR has traded an average of 950.36K shares per day and 1067210 over the past ten days. A total of 65.11M shares are outstanding, with a floating share count of 53.16M. Insiders hold about 18.37% of the company’s shares, while institutions hold 95.94% stake in the company. Shares short for KYMR as of 1749772800 were 7582895 with a Short Ratio of 7.98, compared to 1747267200 on 6995367. Therefore, it implies a Short% of Shares Outstanding of 7582895 and a Short% of Float of 14.71.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
